Literature DB >> 23316006

A deletion mutation in TMEM38B associated with autosomal recessive osteogenesis imperfecta.

Michael Volodarsky1, Barak Markus, Idan Cohen, Orna Staretz-Chacham, Hagit Flusser, Daniella Landau, Ilan Shelef, Yshaia Langer, Ohad S Birk.   

Abstract

Autosomal recessive osteogenesis imperfecta (OI) was diagnosed in three unrelated Israeli Bedouin consanguineous families. Fractures were evident in all cases in infancy. Genome-wide linkage analysis ruled out association with any of the known OI genes, and identified a single homozygosity locus of approximately 2 Mb on chromosome 9 common to all affected individuals (maximum multipoint lod score 6.5). Whole exome sequencing identified only a single mutation within this locus that was shared by all affected individuals: a homozygous deletion mutation of exon 4 of TMEM38B, leading to an early stop codon and a truncated protein, as well as low TMEM38B mRNA levels. TMEM38B encodes TRIC-B, a ubiquitous component of TRIC, a monovalent cation-specific channel involved in Ca(2+) release from intracellular stores that has been shown to act in cell differentiation. Molecular mechanisms through which a TMEM38B mutation might lead to an OI phenotype are yet to be explored.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23316006     DOI: 10.1002/humu.22274

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  34 in total

1.  Two novel mutations in TMEM38B result in rare autosomal recessive osteogenesis imperfecta.

Authors:  Fang Lv; Xiao-Jie Xu; Jian-Yi Wang; Yi Liu; Jia-Wei Wang; Li-Jie Song; Yu-Wen Song; Yan Jiang; Ou Wang; Wei-Bo Xia; Xiao-Ping Xing; Mei Li
Journal:  J Hum Genet       Date:  2016-02-25       Impact factor: 3.172

2.  Novel Deletion of SERPINF1 Causes Autosomal Recessive Osteogenesis Imperfecta Type VI in Two Brazilian Families.

Authors:  Renata Moldenhauer Minillo; Nara Sobreira; Maria de Fatima de Faria Soares; Julie Jurgens; Hua Ling; Kurt N Hetrick; Kimberly F Doheny; David Valle; Decio Brunoni; Ana B Alvarez Perez
Journal:  Mol Syndromol       Date:  2014-11-25

Review 3.  IFITM5 mutations and osteogenesis imperfecta.

Authors:  Nobutaka Hanagata
Journal:  J Bone Miner Metab       Date:  2015-06-02       Impact factor: 2.626

Review 4.  Osteogenesis imperfecta due to mutations in non-collagenous genes: lessons in the biology of bone formation.

Authors:  Joan C Marini; Adi Reich; Simone M Smith
Journal:  Curr Opin Pediatr       Date:  2014-08       Impact factor: 2.856

Review 5.  Osteogenesis imperfecta: diagnosis and treatment.

Authors:  A Biggin; C F Munns
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

6.  Genetic analysis of osteogenesis imperfecta in the Palestinian population: molecular screening of 49 affected families.

Authors:  Osama Essawi; Sofie Symoens; Maha Fannana; Mohammad Darwish; Mohammad Farraj; Andy Willaert; Tamer Essawi; Bert Callewaert; Anne De Paepe; Fransiska Malfait; Paul J Coucke
Journal:  Mol Genet Genomic Med       Date:  2017-11-18       Impact factor: 2.183

Review 7.  Trimeric intracellular cation channels and sarcoplasmic/endoplasmic reticulum calcium homeostasis.

Authors:  Xinyu Zhou; Peihui Lin; Daiju Yamazaki; Ki Ho Park; Shinji Komazaki; S R Wayne Chen; Hiroshi Takeshima; Jianjie Ma
Journal:  Circ Res       Date:  2014-02-14       Impact factor: 17.367

8.  Isolated foveal hypoplasia with secondary nystagmus and low vision is associated with a homozygous SLC38A8 mutation.

Authors:  Yonatan Perez; Libe Gradstein; Hagit Flusser; Barak Markus; Idan Cohen; Yshaia Langer; Mira Marcus; Tova Lifshitz; Rotem Kadir; Ohad S Birk
Journal:  Eur J Hum Genet       Date:  2013-09-18       Impact factor: 4.246

Review 9.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

Review 10.  New genes in bone development: what's new in osteogenesis imperfecta.

Authors:  Joan C Marini; Angela R Blissett
Journal:  J Clin Endocrinol Metab       Date:  2013-06-14       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.